Related Experiment Video
Updated: Jul 14, 2026
06:16
Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model
Published on: April 19, 2024
Unchecked thrombin is bad news for troubled arteries
1Cardiovascular Research Institute, UCSF, San Francisco, California 94158-2517, USA. eric.camerer@ucsf.edu
The Journal of Clinical Investigation
|June 6, 2007
Summary
Thrombin contributes to arterial narrowing and clotting by promoting structural changes in artery walls. Reduced levels of heparin cofactor II worsen these changes, suggesting a novel therapeutic target for atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Thrombosis Research
- Atherosclerosis Pathogenesis
Background:
- Thrombin is a critical factor in thrombosis and a major cause of mortality in atherosclerotic cardiovascular disease.
- The role of thrombin in long-term structural arterial wall changes remains incompletely understood.
Discussion:
- Aihara et al. investigated the role of heparin cofactor II (HCII), a thrombin inhibitor, in arterial lesion development.
- The study utilized a mouse model to examine the impact of HCII deficiency on injury- or hyperlipidemia-induced arterial lesions.
Key Insights:
- Haploinsufficiency of heparin cofactor II exacerbates arterial lesion formation in mice.
- Excessive thrombin signaling, potentially via protease-activated receptors, is implicated in promoting arterial wall changes.
- This suggests a dual role for thrombin in both acute clotting and chronic arterial remodeling.
Outlook:
- Further research is needed to elucidate the precise mechanisms of thrombin-mediated arterial remodeling.
- Targeting thrombin signaling pathways could offer new therapeutic strategies for preventing or treating atherosclerosis progression.
More Related Videos
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...